Pharmacokinetic changes of a new proton pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with uranyl nitrate- induced acute renal failure

Research Communications in Molecular Pathology and Pharmacology

Volumn 102, Issue 1, 1998, Pages 43-56

  Kim, Ho J ^a   Han, Kye S ^a   Chung, Young K ^b   Chang, Man S ^b   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Yungjin Pharm Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 BUTYRYL 4 (5 METHYLBENZYLAMINO) 8 ETHOXY 1,7 NAPHTHYRIDINE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; URANYL NITRATE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SCREENING; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; NAPHTHYRIDINES; PROTON PUMPS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; URANYL NITRATE;

EID: 0032446933     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chiou, W.L. (1978): Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm., 6, 539-546.
2. Chiou, W.L. (1979): New calculation method for mean apparent drug volume of distribution and application to rationale dosage regimens. J. Pharm. Sci., 68, 1067-1069.
3. Chiou, W.L. (1980): New calculation method of mean total body clearance of drugs and its application to dosage regimens. J. Pharm. Sci., 69, 90-91.
4. Chung, S.Y., Han, K.S., Chung, Y.-K., Chang, M.S. and Lee, M.G. (1998): Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8. Res. Commun. Mol. Pathol. Pharmacol., 100, 187-200.
5. Eatman, F.B., Colburn, W.A., Boxenbaum, H.G., Posmanter, H.N., Weinfeld, R.E., Ronfeld, R., Weissman, L., Moore, J.D., Gibaldi, M. and Kaplan, S.A. (1977): Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J. Pharmacokinet. Biopharm., 5, 481-494.
6. Engineer, M.S., Ho, D.-H. and Bodey, O.P. Sr. (1986): Comparison of vancomycin disposition in rats with normal and abnormal renal functions. Antimicrob. Agents Chemother., 20, 718-722.
7. Fruncillo, R.J., Swanson, B.N., Bernhard, R., Marchion, C. and Ferguson, R.K. (1986): Effect of renal failure or biliary stasis on the pharmacokinetics of amiodarone in the rat. J. Pharm. Sci., 75, 150-154.
8. Garcia, M.J., Dominguez-Gil, A.A., Cepeda, M. and Dominguez-Gil. A. (1981): Pharmacokinetics of a cefoxitin administered intravenously to rabbits with experimentally-induced renal impairment. Biopharm. Drug Dispos., 2, 205-213.
9. Gibaldi, M. and Perrier, D. (1982): Pharmacokinetics, 2nd ed. Dekker, New York.
10. Itoh, T., Sawada, Y., Lin, T.H., Iga, T. and Hanano, M. (1988): Kinetic analysis of phenytoin disposition in rats with experimental renal and hepatic diseases. J. Pharmacobiodyn., 11, 289-308.
11. Katayama, H., Fujiwara, J., Yasuhara, M., Okumura, K. and Hori, R. (1984): Increased bioavailability of propranolol in rats with uranyl nitrate-induced acute renal failure. J. Pharmacobiodyn., 7, 536-544.
12. Kim, O.N. (1991): Pharmacokinetics of theophylline in experimental acute renal failure rats (I). Yakhak Hoeji., 35, 38-44.
13. Kim, S.H., Choi, Y.M. and Lee, M.G. (1993): Pharmacokinetics and pharmacodymics of furosemide in protein-calorie malnutrition. J. Pharmacokinet. Biopharm., 21, 1-17.
14. Kim, S.H., Shim, HJ., Kim, W.B. and Lee, M.G. (1998): Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure. Antimicrob. Agents Chemother., 42, 1217-1221.
15. Kim, Y.G., Yoon, E.J., Yoon, W.H., Shim, HJ., Lee, S.D., Kim, W.B., Yang, J. and Lee, M.G. (1996): Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to uranyl nitrate-induced acute renal failure rats or protein-calorie malnutrition rats. Biopharm. Drug Dispos., 17, 183-195.
16. Lee, Y.-H., Lee, M.-H. and Shim, C.-K. (1992): Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure. Pharm. Res., 9, 1599-1606.
17. Lee, H.J., Paik, W.H. and Lee, M.G. (1996): Pharmacokinetic and tissue distribution change of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats. Res. Commun. Mol. Pathol. Pharmacol., 91, 195-204.
18. Lin, J.H. and Levy, G. (1982): Effect of experimental renal failure on sulfate retention and acetaminophen pharmacokinetics in rats. J. Pharmacol. Exp. Ther., 221, 80-84.
19. Lin, J.H. and Lin, T.-H. (1988): Renal handling of drugs in renal failure I: Differential effects of uranyl nitrate- and glycerol-induced acute renal failure on renal excretion of TEAB and PAH in rats. J. Pharmacol. Exp. Ther., 246, 896-901.
20. Mariño, E.L., Pajares, M., Dominguez-Gil, A.A., Cepeda, M. and Dominguez-Gil, A. (1981): Disposition of cefadroxil administered orally to rabbits with experimentally induced renal impairment. Arzneimit-Forsch, 31, 1459-1461.
21. Matzke, G.R. and Millikin, S.P. (1992): Chapter 8. Influence of renal function and dialysis on the drug disposition. In Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring. 3rd ed. W. E. Evans, J. J. Schentag and W. J. Jusko, Applied Therapeutics Inc., Vancouver, WA. 3rd Edn. pp. 8-10.
22. Park, J.M., Moon, C.-H. and Lee, M.G. (1996): Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats. Res. Commun. Mol. Pathol. Pharmacol., 93, 353-362.
23. Park, K.J., Yoon, W.H., Kim, S.H., Shin, W.G. and Lee, M.G. (1998): Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration of azosemide to uranyl nitrate-induced acute renal failure rats. Biopharm. Drug Dispos., 19, 141-146.
24. Terao, N. and Shen, D.D. (1984): Pharmacokinetics of /-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats. J. Pharmacokinet. Biopharm., 12, 479-493.